MENU
TENX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Tenax Therapeutics (TENX) Ownership - Who owns Tenax Therapeutics?

Profile

Industry
Medical Specialties
Address
101 Glen Lennox Drive
Phone
+1 919 855-2100
Employees
6
Web
https://www.tenaxthera.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
19.12M
P/E Ratio
N/A
Total Cash
98.31M
Projected Growth
N/A
Total Debt
278.8K
Revenue
N/A
Risk (Beta)
2.00
Dividend Yield
N/A
Total Cash/Share
28.84
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

TENX
Capitalization
19.1M
P/E Ratio
N/A
Risk (Beta)
2.00
Dividend Yield
N/A
Total Cash
98.3M
Total Cash/Share
28.84
Total Debt
279K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
97.2M
P/B Ratio
0.20
Cash Flow
N/A
Earnings
-13.05
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
341
Current Ratio
38.95
Current Revenue Per Employee
4107.17
Dividends Per Share - Security
N/A
EBITDA
-14.53M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-26.08
Shares Held By Institutions
4.39M
Shares Outstanding - Current
3.41M
Total Liabilities
2.56M
Total Volume MTD
N/A
Value
1
Gain YTD
-74.463
View a ticker or compare two or three
TENX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of novel therapeutic products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
101 Glen Lennox Drive
Phone
+1 919 855-2100
Employees
6
Web
https://www.tenaxthera.com